Mats Holmberg - Concepedia

Author

Mats Holmberg

Karolinska University Hospital ORCID

Also Known As

Holmberg M, Holmberg, Mats, M Holmberg, M. Holmberg, Mats Holmberg, Mats Olof Holmberg, Molly A. Holmberg

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet University of Gothenburg Aalborg University Hospital Sahlgrenska University Hospital

About

Mats Holmberg is an author at Karolinska University Hospital specializing in gender identity, social sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	166
2	Social Sciences	3	3	156
3	Endocrinology	3	3	166
4	Gender Studies	3	3	155
5	Education	1	1	24

Mats Holmberg

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen, Neuro-Oncology	2010	227
Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals Anna Wiik, Tommy R. Lundberg, Eric Rullman, The Journal of Clinical Endocrinology & Metabolism	2019	108
Immune system adaptation during gender-affirming testosterone treatment Tadepally Lakshmikanth, Camila Rosat Consiglio, Fabian Sardh, Nature Gender IdentityImmune System AdaptationGender StudiesImmunologySex Differences	2024	97
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism Gabriel Sjölin, Mats Holmberg, Ove Törring, Thyroid	2019	96
Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey Ove Törring, Torquil Watt, Gabriel Sjölin, Thyroid	2019	88
A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy Søren Møller, Kirsten Grunnet, Steinbjørn Hansen, Acta Oncologica	2012	61
Docetaxel rechallenge after an initial good response in patients with metastatic castration‐resistant prostate cancer Stéphane Oudard, Gero Kramer, Orazio Caffo, British Journal of Urology	2014	58
MRI target delineation may reduce long-term toxicity after prostate radiotherapy Lotte Sander, Niels Christian Langkilde, Mats Holmberg, Acta Oncologica	2013	56
A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer Jimmi Søndergaard, Mats Holmberg, Annette Ross Jakobsen, Acta Oncologica	2014	40
Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage? Søren Ravn, Mats Holmberg, Preben Sørensen, Acta Oncologica	2013	36

Page 1